Chemours (CC) PT Lowered to $18 at Morgan Stanley

August 10, 2026 8:36 AM

Morgan Stanley analyst Vincent Andrews lowered the price target on Chemours (NYSE: CC) to $18.00 (from $21.00) while maintaining a Equalweight rating.

No results found